Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Positive phase I results for Acrux's combination contraceptive spray

July 6, 2007

Snapshots of miscellaneous treatments for diabetes from the ADA meeting

July 6, 2007

MK-0364, MK-0493 studied in obese subjects

July 6, 2007

PKC-delta: a new target for the treatment of hepatic insulin resistance

July 6, 2007

Regulatory guidance on pivotal program for Chronocort

July 5, 2007

Clinical trials on rhGH formulations reported at ESPE

July 5, 2007

Studies show favorable pharmacokinetics, reduced costs with CERA

July 5, 2007

Maxygen begins phase IIa trial of MAXY-G34 for breast cancer

July 5, 2007

Recent patents disclose novel agents for obesity and disorders of lipoprotein metabolism

July 5, 2007

Recent clinical results with new insulin formulations

July 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...